Clinical Trials Open To Enrollment

Currently Enrolling Clinical Trials for Patients with Memory Loss

  • An 18-month trial investigating an infusion-based treatment which may target amyloid plaque in the brain for people with mild cognitive impairment and mild Alzheimer’s disease.
  • A 96-week trial investigating an infusion-based treatment which may target tau protein in the brain. This study is for patients with mild cognitive impairment and mild Alzheimer’s disease.
  • An 18-month trial investigating an oral medication, which may inhibit a particular enzyme known to be part of the amyloid production process. This study is for individuals with mild Alzheimer’s disease.
  • A 6-month study investigating an oral medication which may increase signaling of neurons in the brain. Subjects must be on 10mg donepezil and either 20mg or 28mg (XR) of memantine to participate in this program. This study is for patients with mild to moderate Alzheimer’s disease.

  • A 5-month  study investigating transcranial electromagnetic technology,which may break down the structure of amyloid plaques.This study is for patients with mild to moderate Alzheimer's Disease.

  • A 4-year observational study involving neurocognitive testing and imaging, which may help to learn more about Alzheimer's disease. This study is for individuals 55-90 years old with mild cognitive impairment  or mild Alzheimer's disease.

Currently Enrolling Clinical Trials for Patients without Memory Loss

  • A 4 ½-year prevention study investigating and oral medication, which may inhibit a particular enzyme known to be part of the amyloid production process. This study is for individuals 65-85 years old (or 60-64 with a parent or sibling with Alzheimer's)  who are concerned about developing Alzheimer’s disease but currently have no memory problems.

  • A 5-year prevention study investigating both an oral medication and an injected treatment (randomly assigned to one treatment or placebo). This study is for individuals 60-75 years old who are concerned about developing Alzheimer's due to their genotype but  currently have no memory problems.

  • A 4-year observational study involving neurocognitive testing and imaging, which may help to learn more about Alzheimer's. This study is for individuals 65-90 years old with no memory problems.

We always have new trials just around the corner! Please check back with us for updates.

For more information about our programs, please contact:

 Kelly Rodrigo at 813-974-4904 or email krodrig5@health.usf.edu

Haitham Abulaban at 813-974-9383 or email habulaban@heatlh.usf.edu